Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Thermo Fisher
Pharma
2025's top biopharma M&A deals
Looming patent expirations and a thawing of the biotech investment scene prompted drug developers of all stripes to pull out their checkbooks in 2025.
Fraiser Kansteiner
,
Zoey Becker
,
Angus Liu
,
Kevin Dunleavy
,
Eric Sagonowsky
,
Andrea Park
Jan 12, 2026 3:00am
NC all in on workforce development to drive local life sci boom
Jul 28, 2025 3:20pm
Thermo Fisher snaps up Sanofi fill-finish plant in New Jersey
Jul 16, 2025 10:49am
Thermo Fisher buys 3M spinoff's filtration unit for $4.1B
Feb 25, 2025 10:45am
Thermo Fisher will lay off 300 in Massachusetts as cuts continue
Feb 3, 2025 11:21am
Sales up 23% for Korean CDMO powerhouse Samsung Biologics
Jan 22, 2025 11:41am
